2001The Chinese Journal of Clinical PharmacologyRequires access

24-Hour Blood Pressure Control by Once-daily Administration of Losartan Assessed by Ambulatory Blood Pressure Monitoring

Li Yi

Open publisher page 0 citations

Abstract

OBJECTIVE: To assess 24h ambulatory blood pressure lowerings and tolerability after weeks of therapy with losartan 50-100mg once daily. METHOD: After 1-week wash-out and 2-weeks placebo run-in, patients with seated diastolic blood pressure (SeDBP) 95-115mmHg and ambulatory diastolic blood pressure ≥ 85 mmHg were investigated by openlabel method with losartan 50mg treatment for 4 weeks, followed by dose titration to 100mg once-daily for another 4 weeks in those patients with SeDBP≥90mmHg. Ambulatory blood pressure monitoring (ABPM) was performed over 24-hour period after placebo run-in and at the end of weeks. RESULTS:Mean reductions from baseline in 24h, day -time (6:00-22:00), night-time (22:00-6:00) were (11.0 ?9.5/6.8 ?5.8),(11.5 ?10.8/7.0 ?6.2),(10.2 ?9.5/6.6 ? 7.0) mmHg. Trough: peak ratios were 75.5% for DBP and 74.5% for SBP. The frequency of adverse events was very low, and no cough happened. CONCLUSION: losartan 50- 100mg given once daily appears to be a well-tolerated, safe,and effective antihypertensive treatment.

About this research paper

What this paper is about

OBJECTIVE: To assess 24h ambulatory blood pressure lowerings and tolerability after weeks of therapy with losartan 50-100mg once daily. METHOD: After 1-week wash-out and 2-weeks placebo run-in, patients with seated diastolic blood pressure (SeDBP) 95-115mmHg and ambulatory diastolic blood pressure ≥ 85 mmHg were investigated by openlabel method with losartan 50mg treatment for 4 weeks, followed by dose titration to 100mg once-daily for another 4 weeks in those patients with SeDBP≥90mmHg. Ambulatory blood pressure monitoring (ABPM) was performed over 24-hour period after placebo run-in and at the end of weeks. RESULTS:Mean reductions from baseline in 24h, day -time (6:00-22:00), night-time (22:00-6:00) were (11.0 ?9.5/6.8 ?5.8),(11.5 ?10.8/7.0 ?6.2),(10.2 ?9.5/6.6 ? 7.0) mmHg. Trough: peak ratios were 75.5% for DBP and 74.5% for SBP. The frequency of adverse events was very low, and no cough happened. CONCLUSION: losartan 50- 100mg given once daily appears to be a well-tolerated, safe,and effective antihypertensive treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To assess 24h ambulatory blood pressure lowerings and tolerability after weeks of therapy with losartan 50-100mg once daily. METHOD: After 1-week wash-out and 2-weeks placebo run-in, patients with seated diastolic blood pressure (SeDBP) 95-115mmHg and ambulatory diastolic blood pressure ≥ 85 mmHg were investigated by openlabel method with losartan 50mg treatment for 4 weeks, followed by dose titration to 100mg once-daily for another 4 weeks in those patients with SeDBP≥90mmHg. Ambulatory blood pressure monitoring (ABPM) was performed over 24-hour period after placebo run-in and at the end of weeks. RESULTS:Mean reductions from baseline in 24h, day -time (6:00-22:00), night-time (22:00-6:00) were (11.0 ?9.5/6.8 ?5.8),(11.5 ?10.8/7.0 ?6.2),(10.2 ?9.5/6.6 ? 7.0) mmHg. Trough: peak ratios were 75.5% for DBP and 74.5% for SBP. The frequency of adverse events was very low, and no cough happened. CONCLUSION: losartan 50- 100mg given once daily appears to be a well-tolerated, safe,and effective antihypertensive treatment.

Key concepts: Medicine, Ambulatory blood pressure, Blood pressure, Tolerability, Losartan, Placebo, Ambulatory, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
24-Hour Blood Pressure Control by Once-daily Administration of Losartan Assessed by Ambulatory Blood Pressure Monitoring — Research Paper | ScholarLens